Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to reflect a new version of the study, now labeled as v2.15.0, and includes a new focus on specific types of solid tumors, including head and neck cancer and lung cancer. The previous study details regarding the purpose and inclusion/exclusion criteria have been removed.SummaryDifference15%
- Check13 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check56 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check71 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference2%
- Check78 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check92 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.